What is the prevalence of Anencephaly?

Anencephaly is a rare, fatal neural tube defect occurring in approximately 1 in every 1,000 to 10,000 pregnancies worldwide, though incidence varies significantly by region and maternal nutrition. Because the condition is universally fatal shortly after birth, there is no "prevalence" of living individuals, and the condition is classified as a severe, non-survivable congenital malformation.

What is the global incidence of Anencephaly?

The incidence of Anencephaly is heavily influenced by folic acid intake and public health initiatives. According to the CDC and NIH GARD, the condition affects roughly 1,000 to 2,000 pregnancies in the United States annually. However, global statistics fluctuate; in some countries, the rate is much higher due to nutritional deficiencies and limited access to prenatal screening. It is important to note that these figures are estimates; true incidence data is often masked by high rates of pregnancy termination or spontaneous miscarriage.

Are there variations in how Anencephaly occurs?

Anencephaly exhibits specific demographic patterns that researchers continue to study:

• Gender Distribution: Anencephaly is observed more frequently in female fetuses than in males, with a ratio of approximately 3:1 to 4:1.


• Geographic/Ethnic Trends: Higher rates have historically been reported in parts of the United Kingdom, Ireland, and among certain Hispanic populations in the United States.


• Age of Onset: This is a congenital condition; it is diagnosed during the first or second trimester of pregnancy. There are no adult cases of Anencephaly, as the condition is incompatible with life.

Why is accurate data for Anencephaly difficult to track?

Tracking the true incidence of Anencephaly is challenging due to the significant number of cases that result in early pregnancy loss or elective termination. Many registries only capture live births, which significantly underestimates the total number of affected pregnancies. Within the DiseaseMaps.org community, 31 members have shared their experiences, providing a vital, human-centered perspective that complements the clinical data gathered by global health organizations.

Next steps

• Consult with a genetic counselor or maternal-fetal medicine specialist if you have received a diagnosis or have concerns about recurrence risk.


• Connect with the 31 members of the DiseaseMaps.org community to share experiences and find emotional support.


• Speak with a bereavement counselor or specialized support group to navigate the complex grief associated with a fatal prenatal diagnosis.

Medical disclaimer: This information is for educational purposes only and does not constitute professional medical advice, diagnosis, or treatment.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Anencephaly overview.


• Centers for Disease Control and Prevention (CDC): Data and statistics on neural tube defects.


• Orphanet: Rare disease database entry for Anencephaly.


• World Health Organization (WHO): Neural tube defects and folic acid fortification data.